You are here

IT IS THE OBJECTIVE OF THIS PROJECT TO PRODUCE PROTOTYPE SAMPLES OF ZIGMED'S SELF-CONTAINED AMBULATORY INTRA-VENOUS INFUSTION SYSTEM (SAIVIS) FOR IN-VITRO, AND POSSIBLY IN-VIVO, TESTING.

Award Information
Agency: Department of Defense
Branch: Army
Contract: N/A
Agency Tracking Number: 4579
Amount: $49,852.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1986
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
16 Merry Lane
East Hanover, NJ 07936
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ZSIGMOND L SAGI
 (201) 887-3542
Business Contact
Phone: () -
Research Institution
N/A
Abstract

IT IS THE OBJECTIVE OF THIS PROJECT TO PRODUCE PROTOTYPE SAMPLES OF ZIGMED'S SELF-CONTAINED AMBULATORY INTRA-VENOUS INFUSTION SYSTEM (SAIVIS) FOR IN-VITRO, AND POSSIBLY IN-VIVO, TESTING. ZIGMED'S INTRAVENOUS DELIVERY SYSTEM IS A LIGHTWEIGHT, ARM-MOUNTED HOUSING WHICH CONTAINS AN INTERNAL POWER SOURCE AND ALL WORKING COMPONENTS, AND ACCEPTS I.V. BAGS OF ALL CAPACITIES. THE DEVICE IS DESIGNED TO BE A SELF-CONTAINED INTRAVENOUS SYSTEM, COMPRISING A RIGID SHELL HOUSING THE I.V. BAG AND A FLUID PROPULSION MEANS. IN USE, THE SHELL CONTAINING ALL COMPONENTS (INCLUDING THE POWER SOUCE) STRAPS ON THE PATIENT'S ARM NEAR THE INFUSION SITE.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government